The molecular mechanism of action of general anesthetics: structural aspects of interactions with GABA(A) receptors.
(1) Considerable evidence has accumulated that the molecular target of general anesthetics in the central nervous system is the GABA(A) receptor, the major mediator of inhibitory synaptic transmission. This receptor is actually a family of ligand-gated chloride channel proteins, each a heteropentameric membrane-spanning structure. (2) Regional variation in anesthetic actions on the central nervous system may parallel a corresponding regional variation in pharmacological subtypes of GABA(A) receptors. These result from differential regional expression of approximately 18 subunit genes. (3) Receptors of varying subunit composition show differential sensitivity to GABA, modulatory drugs, and biological regulatory mechanisms. Regional variation in allosteric modulation of GABA(A) receptor binding and function can be reconstituted in certain recombinant receptor subunit combinations expressed in heterologous cells. (5) Differential sensitivity to anesthetics for various GABA(A) receptor subunits also allows the use of the chimeric and site-directed mutagenesis approach in attempting to define domains of the protein which participate in the binding and actions of anesthetics.
Department of Molecular and Medical Pharmacology, School of Medicine, Brain Research Institute, Mental Retardation Research Center, University of California, Los Angeles 90095-1735, USA.
R W
RW
Olsen
D018681:Anesthetics, General / Q000737:chemistry* / Q000494:pharmacology*; D000818:Animals; D006801:Humans; D011487:Protein Conformation; D011963:Receptors, GABA-A / Q000737:chemistry* / Q000187:drug effects* / Q000235:genetics
D018681:Anesthetics, General; D011963:Receptors, GABA-A